Gene Editing Market, By Application, By Technology, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

REPORT HIGHLIGHT

Gene Editing Market size was valued at US$ 4,767.12 Million in 2024, expanding at a CAGR of 10.5% from 2025 to 2032.

Gene editing is the purposeful alteration of the DNA of an organism's DNA molecular technology to insert, delete, or modify genetic material at a targeted site within the genome. This process makes achieving precise, targeted modifications to the DNA sequence possible, which is immensely useful in medicine, agriculture, and biotechnology. Unlike the older form of genetic modification, which means the addition of foreign genes into an organism, gene editing specifically alters the native genetic code. CRISPR/Cas9, TALENs (Transcription Activator-Like Effector Nucleases), and Zinc Finger Nucleases (ZFNs) have all been pivotal in advancing the science of gene editing to become more available, precise, and economical. These technologies permit scientists to alter the genes of living organisms to bring advancements in genetic disease areas, enhanced yields of crops, and gene treatments for previously intractable disorders.

Gene Editing Market- Market Dynamics

The growing demand for genetic therapy and personalized medicine drives the gene editing market. With increased accuracy in treatment offered by developing CRISPR/Cas9 & other gene editing technologies, the healthcare sector is increasingly looking to gene editing to treat genetic disorders like hemophilia, cystic fibrosis, and sickle cell anemia. More than 5,000 genetic diseases are potentially treatable with gene therapy, as per a report by the National Institutes of Health (NIH). Government support and funding, especially in nations such as the United States and China, have also driven research and development activities in gene editing. The emergence of biotech & pharma firms using gene editing to speed up drug discovery also contributes to the market's growth.

In addition, the increasing use of gene editing in agriculture, including the creation of pest- and disease-resistant crops, justifies the industry's growth. The market is also driven by increasing interest in cell lines and animal genetic engineering, where gene editing can create better disease models and produce biopharmaceuticals. The increasing use of gene editing in regenerative medicine has tremendous growth potential. More investments by both the private & public sectors will most probably drive innovation and hasten the commercialization of gene-editing technologies, making way for new treatments and applications. However, ethical issues in human germline editing, Regulatory hurdles, and the cost & complexity of gene-editing technologies may hamper market growth.

Gene Editing Market- Key Insights

Cell line engineering holds the biggest share of the gene editing market because it has been applied very broadly in drug discovery, biopharmaceutical manufacturing, and cell-based therapies. Its ability to generate immortalized cell lines for therapy has contributed to its advancement.

Animal genetic engineering is projected to grow rapidly due to advancing livestock, disease resistance, and customized veterinary medicine. Genetic modification in animals, such as increasing disease-resistant livestock, is critical to improving food security, and the industry is gaining pace.

CRISPR/Cas9 is the dominant technology in gene editing due to its accuracy, efficiency, and affordability, making a researcher's preference globally. Its use in medicine, agriculture, and the biotech industry is becoming wider, and it is the current market leader in technology.

Zinc Finger Nucleases (ZFNs) are the fastest-growing technology used for therapeutic gene editing. ZFNs are more useful for precise human cell changes, driving clinical application and therapy expansion.

Pharmaceutical and biotech firms are the market leaders, using gene editing technologies to create new treatments for genetic diseases. Their heavy investments in R&D and strategic collaborations are driving the use of gene-editing solutions in the healthcare sector.

Gene Editing Market- Segmentation Analysis:

The Global Gene Editing Market is segmented based on Application, Technology, End-User, and Region.

By Application, the gene editing market is divided into Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Others. Cell Line Engineering held the highest share in the market, attributed to its crucial role in drug discovery, vaccine development, and biopharmaceutical production. It enables the development of stable, high-producing cell lines critical for producing biologics & monoclonal antibodies. The strong growth in personalized medicine, particularly the emergence of customized cancer treatments, further establishes the role of cell line engineering. The most rapidly growing segment is Animal Genetic Engineering, owing to innovation in gene-editing tools that enable animal manipulation to enhance farm yields, disease resistance, and animal well-being. Since genetically modified animals have gained popularity, this technology's applications in making food production more efficient and helping improve global food security issues will boost its development faster.

By Technology, the gene editing market is divided into CRISPR/Cas9, Zinc Finger Nucleases (ZFNs), TALENs, and Others. The CRISPR/Cas9 technology segment leads the market because of its unmatched precision, efficiency, and popularity. The high precision and low price of CRISPR/Cas9 compared with older technologies such as ZFNs and TALENs make it the most used and prevalent option among researchers. This technology has revolutionized gene editing in all application areas, ranging from agricultural improvements to the creation of gene therapies. The fastest-growing technology is Zinc Finger Nucleases (ZFNs). ZFNs are growing at a rapid pace, particularly in the clinic, where the accuracy of gene editing in human cells is highly important. ZFNs are under investigation for curing genetic disorders such as sickle cell anemia & hemophilia and, thus, represent a key technology for therapeutic applications.

Gene Editing Market- Geographical Insights

North America acquired the highest market share, spurred by heavy investments in biotechnology, strong research infrastructure, and supportive government policies. The US is a leader in gene-editing research & development, with the FDA endorsing gene therapy trials. North America is a base of top biotech companies & research centers. The region is expected to grow further, driven by the rising need for targeted medicine and the quick evolution of gene therapies. The rapidly growing area is Asia-Pacific, which is mainly driven by the growing investment in biotechnology in China & Japan. Countries are rapidly embracing advanced gene-editing tools for both medical and agricultural purposes. The need for gene-modified crops and increasing interest in gene therapies is propelling the market with China as a major contributor in research & clinical trials of gene editing. The Asia-Pacific region can potentially have high growth rates driven by government encouragement and enhanced healthcare infrastructure.

Gene Editing Market- Competitive Landscape:

The gene editing market is highly competitive, with numerous leading players in the global market. Horizon Discovery Ltd., Sangamo Therapeutics, Inc., GenScript, and Thermo Fisher Scientific Inc. are the key contributors to the technological advancement of the market. The key players invest significantly in R&D to improve their gene-editing tools, with a target on CRISPR/Cas9 and other emerging technologies. Strategic partnerships & collaborations and developing new gene-editing products are key strategies for maintaining market competitiveness. Intellia Therapeutics, CRISPR Therapeutics, and Caribou Biosciences, Inc. are also leading clinical trials focusing on gene therapies for genetic disorders, which will shape the market's future. Market competition also emphasizes technological innovation, regulatory clearance, and clinical approval, enabling market leaders to dominate the emerging gene-editing market.

Recent Developments:

January 2025: Beam Therapeutics launched the first clinical trial site for its Phase 1/2 clinical trial of BEAM-301, an in vivo base editor in development for the possible treatment of glycogen storage disease type 1a (GSD1a).

December 2024: Beam Therapeutics announced the first data from its BEACON Phase 1/2 clinical trial of BEAM-101 in sickle cell disease at the American Society of Hematology (ASH) Annual Meeting.

December 2024: Intellia Therapeutics dosed the initial patient in its worldwide Phase 3 HAELO study assessing NTLA-2002 for hereditary angioedema (HAE).

March 2024: GenScript partnered with PersonGen-Anke Cellular Therapeutics to advance cell isolation products. The collaboration improved cell therapy development & production efficiency.

February 2024: CRISPR Therapeutics reported strong Phase 1 clinical trial data for CTX310, in an in vivo gene-editederapy to remove ANGPTL3, for the potential treatment of hypercholesterolemia and hypertriglyceridemia.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENE EDITING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Horizon Discovery Ltd.
Sangamo Therapeutics, Inc.
GenScript
Integrated DNA Technologies, Inc.
Precision Biosciences
Bearn Therapeutics
Thermo Fisher Scientific Inc.
Intellia Therapeutics, Inc.
CRISPR Therapeutics
Caribou Biosciences, Inc.

GLOBAL GENE EDITING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Others

GLOBAL GENE EDITING MARKET, BY TECHOLOGY- MARKET ANALYSIS, 2019 - 2032

CRISPR/Cas9
Zinc Finger Nucleases (ZFNs)
TALENs
Others

GLOBAL GENE EDITING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Biotech And Pharma Companies
Contract Research Organizations (CROs)
Research Institutes

GLOBAL GENE EDITING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV5042

1. Gene Editing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Gene Editing Market Snippet By Application
- 2.1.2. Gene Editing Market Snippet By Technology
- 2.1.3. Gene Editing Market Snippet By End-User
- 2.1.4. Gene Editing Market Snippet by Country
- 2.1.5. Gene Editing Market Snippet by Region
2.2. Competitive Insights

3. Gene Editing Key Market Trends

3.1. Gene Editing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Gene Editing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Gene Editing Market Opportunities
3.4. Gene Editing Market Future Trends

4. Gene Editing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Gene Editing Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Gene Editing Market Landscape

6.1. Gene Editing Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Gene Editing Market - By Application

7.1. Overview
- 7.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 7.1.2. Cell Line Engineering
- 7.1.3. Animal Genetic Engineering
- 7.1.4. Plant Genetic Engineering
- 7.1.5. Others

8. Gene Editing Market - By Technology

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
- 8.1.2. CRISPR/Cas9
- 8.1.3. Zinc Finger Nucleases (ZFNs)
- 8.1.4. TALENs
- 8.1.5. Others

9. Gene Editing Market - By End-User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
- 9.1.2. Biotech And Pharma Companies
- 9.1.3. Contract Research Organizations (CROs)
- 9.1.4. Research Institutes

10. Gene Editing Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Gene Editing Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Gene Editing Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.8. UK
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.8.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.9. France
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.9.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.10. Italy
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.10.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.11. Spain
  - 10.3.11.1. Overview
  - 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.3. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.12. The Netherlands
  - 10.3.12.1. Overview
  - 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.3. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.12.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Overview
  - 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.14. Russia
  - 10.3.14.1. Overview
  - 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.15. Poland
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.16. Rest of Europe
  - 10.3.16.1. Overview
  - 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.16.3. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Gene Editing Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.7. China
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.7.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.8. India
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.12. Indonesia
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.13. Thailand
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. Gene Editing Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. Gene Editing Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.8. UAE
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.8.4. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Gene Editing Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Horizon Discovery Ltd.
- 11.2.2. Sangamo Therapeutics, Inc.
- 11.2.3. GenScript
- 11.2.4. Integrated DNA Technologies, Inc.
- 11.2.5. Precision Biosciences
- 11.2.6. Bearn Therapeutics
- 11.2.7. Thermo Fisher Scientific Inc.
- 11.2.8. Intellia Therapeutics, Inc.
- 11.2.9. CRISPR Therapeutics
- 11.2.10. Caribou Biosciences, Inc.

12. 360 Degree AnalystView

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us